Next Event in the Series:

Partnership Opportunities

Meet the Leading Minds in Global CAR-TCR Development

The ever-growing cell therapy community continue to strive for durable, safe and accessible treatments for oncology, and are now expanding this goal to autoimmune indications too. To achieve this, developers are putting their trust in industry partners to accelerate development and pipeline progression.

The 9th CAR-TCR Summit was the premier meeting in the cell therapy calendar, which provided an unmatched opportunity to connect with decision-makers from small and large biotech, pharma and academia, to spark connections, foster relationships and demonstrated the attendees' commitment to the shared objective of delivering these life-saving treatments to patients.

Get in touch now to begin discussing your bespoke package for 2025.

“Hanson Wade has the leverage to pull the best speaker line-up. Each Hason Wade team member works hard to meet partners’ requests”

Leyna Zhao, Director - Product Management & Marketing, Agilent Technologies

CAR-TCR Sponsor Logos (1)

View the 2024 Floorplan Now!

Orange = SOLD | Grey = Available

View the 9th CAR-TCR Summit 2024 Partnership Prospectus:

What Was New in 2024?

Badge Scanning Technology for Easier Lead Capture

Redesigned
Floorplan for Increased Footfall

Streamlined
Agenda for Increased Audience Size Per Track

“Relevant attendees and informative panels”

Yuki Kato Maves, Associate Director - Product Management, AllCells

AllCells

Who Did the Attendees Meet in 2024?

1,000+ Cell Therapy Experts from Discovery to Supply Chain

C-Level,
Director Level &
VP Level Attendees

Academics, Small & Large Biotech & Pharma Companies

A Snapshot of the 2024 Speaker Faculty:

Amy Emmert

Executive Director, Cell Therapy Facility

Dana Farber Cancer Institute

Arun Pores Fernando

Director, Business Development, Search & Evaluation, Cell Therapy

Bristol Myers Squibb

Carl June

Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies

University of Pennsylvania

Elisa Kieback

Co-Founder & Chief Technology Officer

T-knife Therapeutics

Justin McCue

Chief Technology Officer

TScan Therapeutics

Mythili Koneru

Chief Medical Officer

Legend Biotech

Pascal Touchon

President & Chief Executive Officer

Atara Biotherapeutics

Vicki Plaks

Global Head of Cell Therapy, Translational Research

Johnson & Johnson

“High level of presentations, excellent exhibition of manufacturing equipment”

Andrea Zobel, Senior Director Strategy, AmerisourceBergen

AmerisourceBergen
CAR-TCR-545-300x200
CAR-TCR23-219 (1)
CAR-TCR23-294 (1)
CAR-TCR23-308 (1)
CAR-TCR23-289 (1)
CAR-TCR23-555 (1)